Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/1999
06/17/1999CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
06/17/1999CA2312423A1 Inhibition of membrane-associated viral replication
06/17/1999CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999CA2311681A1 Human interferon-epsilon: a type i interferon
06/17/1999CA2311283A1 Purification and microsequencing of hyaluronidase isozymes
06/17/1999CA2309686A1 Composition useful for providing one-step surgical preparation and drape
06/16/1999EP0922458A1 Potentiation of temozolomide by an ATase inhibitor
06/16/1999EP0922110A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
06/16/1999EP0922105A2 Infectious papillomavirus pseudoviral particles
06/16/1999EP0922100A2 Secreted proteins and polynucleotides encoding them
06/16/1999EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
06/16/1999EP0922030A1 Arylsulfonylamino hydroxamic acid derivatives
06/16/1999EP0921822A1 Animal model for transplantation
06/16/1999EP0921821A1 2-methoxyestradiol-induced apoptosis in cancer cells
06/16/1999EP0921819A1 Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
06/16/1999EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
06/16/1999EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0921811A2 Administration of histamine for therapeutic purposes
06/16/1999EP0921808A1 Non-aqueous polar aprotic peptide formulations
06/16/1999EP0921801A1 Inhibitors of farnesyl-protein transferase
06/16/1999EP0921799A1 Methods of inhibiting colon tumors
06/16/1999EP0921794A1 Amino acid composition and use thereof in treating tumor growth and metastasis
06/16/1999EP0921756A1 Novel radiopharmaceutical compositions and matrices and uses thereof
06/16/1999EP0669976B1 Screening method using transcription factor DP-1
06/16/1999EP0542934B1 Use of somatostatin analogues for treating melanomas
06/16/1999EP0491828B1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF
06/16/1999CN1219968A Antibodies to ED-8 domain of fibronectin, their construction and uses
06/16/1999CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
06/16/1999CN1219929A Urea derivatives as inhibitors of IMPDH enzyme
06/16/1999CN1219928A Novel vitamin D analogues
06/16/1999CN1219924A Colchicine-skeleton compounds, their use as medicaments and compounds containing them
06/16/1999CN1219872A Compositions and method for treating or preventing diseases of body passageways
06/16/1999CN1219841A DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
06/16/1999CN1043647C Peptide compound
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912357 Enzyme inhibitors
06/15/1999US5912346 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
06/15/1999US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease
06/15/1999US5912265 Administering silymarin, silybin, silidianin, silicristin, dehydrosilybin or mixtures; antitumor and anticarcinogenic agents
06/15/1999US5912264 Taxane derivatives as antitumor agents
06/15/1999US5912263 13-amino derivatives of taxanes; potent antitumor and -carcinogenic agents
06/15/1999US5912260 Gastrin and CCK antagonists
06/15/1999US5912257 Two-photon upconverting dyes and applications
06/15/1999US5912251 Metabolically inert anti-inflammatory and anti-tumor antifolates
06/15/1999US5912236 Broad-spectrum tumor suppressor genes gene products and methods for tumor suppressor gene therapy
06/15/1999US5912183 Amino acid sequences with phosphorylated tyrosine which interact with intracellular signal transducers and interfere with signal transduction; antimetastasis/anticarcinogenic/ antitumor/antiproliferative agents
06/15/1999US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents
06/15/1999US5912143 Polynucleotides encoding a human mage protein homolog
06/15/1999US5912138 Substrate trapping protein tyrosine phosphatases
06/15/1999US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
06/15/1999US5911995 EGF-genistein conjugates for the treatment of cancer
06/15/1999US5911987 Cell surface protein and effector cell bonding reagent
06/15/1999US5911984 Disorders associated with fatty acid metabolism.
06/15/1999US5911970 Antitumor agents and anticarcinogenic agents
06/15/1999CA2088068C Protein structure of the plant toxin gelonin
06/10/1999WO1999028748A2 Hla-e binding
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028492A1 A method of finding agonist and antagonist to human 11cb splice variant
06/10/1999WO1999028486A1 Methods of isolating and using cd7+cd34-lin-hematopoietic cells
06/10/1999WO1999028345A1 Conjugates useful in the treatment of prostate cancer
06/10/1999WO1999028324A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
06/10/1999WO1999028315A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
06/10/1999WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
06/10/1999WO1999027967A1 Therapeutic agents
06/10/1999WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999WO1999027955A2 Treatment of established chronic infections and cancers
06/10/1999WO1999027947A1 The use of lectin preparations for combating cancers of the bladder
06/10/1999WO1999027936A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
06/10/1999WO1999027935A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
06/10/1999WO1999027919A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods
06/10/1999WO1999027908A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1999015684A3 Expression of genes in hematopoietic stem cells in hischaemic conditions
06/10/1999WO1999015659A3 Human ubiquitin-conjugating enzymes
06/10/1999WO1999015658A3 Human regulatory molecules
06/10/1999WO1999015535A8 Binuclear complex
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999013073A3 Viral vector system capable of expressing an apoptosis-associated gene
06/10/1999WO1999010375A3 Vaccine against hpv
06/10/1999WO1999008684A3 Solutions containing azasteroids
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
06/10/1999WO1998040080A9 Oxyalkylene phosphate compounds and uses thereof
06/10/1999WO1998004582A8 Isolated peptides derived from mage-2
06/10/1999DE19752597A1 Verwendung von Lektinzubereitungen bei der Bekämpfung von Harnblasenkarzinomen Use of Lektinzubereitungen in the fight against bladder cancer
06/10/1999CA2312851A1 Therapeutic and diagnostic methods dependent on cyp2a enzymes
06/10/1999CA2312778A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders
06/10/1999CA2311929A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
06/10/1999CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999CA2311615A1 Conjugates useful in the treatment of prostate cancer
06/10/1999CA2310629A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
06/09/1999EP0921194A2 TRAILLK-2: a member of the TNF ligand family
06/09/1999EP0921193A1 Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy
06/09/1999EP0921130A2 Steroid sulphatase inhibitors
06/09/1999EP0921116A1 N-(4-carbamimido-phenyl)-glycine amide derivatives
06/09/1999EP0920867A1 Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
06/09/1999EP0920630A2 Prion protein binding proteins and uses thereof
06/09/1999EP0920623A1 Boron neutron capture therapy using pre-targeting methods
1 ... 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 ... 2211